Market Herald logo


Be the first with the news that moves the market

Aleafia Health (TSX:AH) earns record quarter-over-quarter revenue in Q1 2023

Source: Aleafia Health Inc.

Aleafia Health (AH) reported its financial results for the three months ended June 30, 2022.

Branded cannabis net revenue increased 24 per cent to a record $10 million from $8 million quarter over quarter. In the key branded adult-use market, the company’s net revenue increased 107 per cent to $6.7 million from $3.2 million in the same period last year. The Market Herald Canada’s Jon Brown Reports.

Click here to read the full story

Weekly Update – Top Cannabis and Psychedelics News Stories

1 | Top Story: Christina Lake Cannabis (CSE:CLC) recaps Q2 results

2 | Innocan Pharma (CSE:INNO) approaches 100 per cent CBD bioavailability for its LPT CBD liposomal delivery platform

3 | Bhang (CSE:BHNG) President/CEO and Director stepping down

4 | The Flowr Corporation (TSXV:FLWR) welcomes new CEO, Chairman, Director

5 | Auxly Cannabis Group (TSX:XLY) sells Auxly Annapolis outdoor facility

Top Cannabis Stocks August 4 to August 10, 2022

1.  T.WEED | 19,584 views | Canopy Growth Corp.
2.  T.HEXO |8,879 views | Hexo Corp.
3.  TLRY | 8,841 views | Tilray Brands Inc.
4. C.TNY | 4,462 views | Tinley Beverage Co Inc.
5. V.LFST | 3,403 views | Lifeist Wellness Inc.
6. C.OILS | 2,785 views | Nextleaf Solutions Ltd.

New to investing in Cannabis? Check out these tips on How to Invest in Cannabis Stocks and some of our Top Cannabis Stocks.

For more of the latest info on Cannabis, check out the Cannabis Trending News hub. Or, for lively sector discussion, visit the Cannabis Bullboards page.

More From The Market Herald

" Silvercorp Metals Inc. Confirms Its Golden Potential with a Reserve and Resource Update

By Dr. Ryan D. Long

" No pain, no blood: BETTER Type 2 diabetes testing is coming to market

Over the past two years, reporting on the Covid-19 pandemic has dominated media airwaves.
The Market Herald Video

" BioVaxys (CSE:BIOV) expands vaccines intellectual property portfolio

BioVaxys Technology Corp. (BIOV) has broadened patent coverage for its viral vaccine platform.
Isracann Biosciences Inc. - CEO, Phil Floucault

" Isracann Bioscience (CSE:IPOT) facilitated genetics arrive in Israel

Isracann Bioscience (IPOT) announces that its first shipment of cannabis strains has cleared Israeli customs and are being raised as mother stock.